UPDATE: Barclays Initiates Coverage On Amgen

By: via Benzinga
Analysts at Barclayson Tuesday initiated coverage of Amgen, Inc. (NASDAQ: AMGN) at Equal-weight, setting a $180 price target ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.